|
|
테두리
|
|
 |
thaXQcauBS |
 |
116 |
|
 |
| Very Good Site http://xhub.in.net/ Beeg Cubist, known for its Cubicin antibiotic, would gain alate-stage Trius drug that has shown promise in treating skininfections. From Optimer, Cubist will acquire the antibacterial,Dificid, which brought in sales of $19.0 million in the quarterended June. |
|
 |
Solomon |
 |
2019-07-10 10:26:31 |
|
|
|
|
|
|
|
|
|
